Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis

Immuno-modulators in combination with antileishmanial drug miltefosine is a better therapeutic approach for treatment of Visceral Leishmaniasis (VL) as it not only reduces the dose of miltefosine but also shortens the treatment regimen. However, immunological mechanisms behind the perceived benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Shivahare, Rahul, Vishwakarma, Preeti, Parmar, Naveen, Yadav, Pawan Kumar, Haq, Wahajul, Srivastava, Mrigank, Gupta, Suman, Kar, Susanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986403/
https://www.ncbi.nlm.nih.gov/pubmed/24732039
http://dx.doi.org/10.1371/journal.pone.0094596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986403/
https://www.ncbi.nlm.nih.gov/pubmed/24732039
http://dx.doi.org/10.1371/journal.pone.0094596

Ejemplares similares